Celgene European Investment Co LLC Insider Trading
Get free email notifications about insider trading for Celgene European Investment Co LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Celgene European Investment Co LLC. Celgene European Investment Co LLC is a 10% Owner in CELGENE CORP /DE/ ($CELG) and a 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and a 10% Owner in Epizyme, Inc. ($EPZM).
Address: 86 MORRIS AVENUE SUMMIT 07901 NJ
Companies in which Celgene European Investment Co LLC is an Insider
AGIOS PHARMACEUTICALS, INC.
Trading Symbol: AGIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Celgene European Investment Co LLC: 10% Owner
Holdings: 1,856,353 shares
Current Value: $82,459,200
Latest Transaction: Apr 24 2017
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CELGENE CORP /DE/
Trading Symbol: CELGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Celgene European Investment Co LLC: 10% Owner
Holdings: 1,856,353 shares
Current Value: $215,819,600
Latest Transaction: Apr 24 2017
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Epizyme, Inc.
Trading Symbol: EPZMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Celgene European Investment Co LLC: 10% Owner
Holdings: 3,674,640 shares
Current Value: $44,279,412
Latest Transaction: Feb 11 2014
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Celgene European Investment Co LLC
Sentiment: All, AGIO, CELG, EPZM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 24 2017 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Buy | P | 49.50 | 624,575 | 30,916,463 | 1,856,353 | 1.2 M to 1.9 M (+50.71 %) |
Apr 24 2017 | CELG | CELGENE CORP /DE/ | Celgene European Investment Co ... | 10% Owner | Buy | P | 49.50 | 624,575 | 30,916,463 | 1,856,353 | 1.2 M to 1.9 M (+50.71 %) |
Dec 17 2014 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Buy | P | 110.75 | 228,645 | 25,322,434 | 1,231,778 | 1 M to 1.2 M (+22.79 %) |
Apr 30 2014 | CELG | CELGENE CORP /DE/ | Celgene European Investment Co ... | 10% Owner | Buy | P | 44.00 | 294,800 | 12,971,200 | 1,003,133 | 708.3 K to 1 M (+41.62 %) |
Apr 30 2014 | AGIO | AGIOS PHARMACEUTIC ... | Celgene European Investment Co ... | 10% Owner | Buy | P | 44.00 | 294,800 | 12,971,200 | 1,003,133 | 708.3 K to 1 M (+41.62 %) |
Feb 11 2014 | EPZM | Epizyme, Inc. | Celgene European Investment Co ... | 10% Owner | Buy | P | 29.25 | 340,000 | 9,945,000 | 3,674,640 | 3.3 M to 3.7 M (+10.20 %) |
Feb 11 2014 | CELG | CELGENE CORP /DE/ | Celgene European Investment Co ... | 10% Owner | Buy | P | 29.25 | 340,000 | 9,945,000 | 3,674,640 | 3.3 M to 3.7 M (+10.20 %) |
View all Celgene European Investment Co LLC insider transactions.